GlaxoSmithKline Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (364)

Latest Posts

About This Stock More About This Stock
GSK Prescribes A US$3.5bn Bond In Three Parts
Article By: Interactive Brokers
Tuesday, March 19, 2019 3:06 PM EDT
British pharma GlaxoSmithKline joined the recent groundswell of high-grade corporate bond issuers Monday to sell new debt.
In this article: GSK Also: NVS, PFE, GILD, BMY, CELG, JUNO, WBA, MSFT, AAPL
Read
GlaxoSmithKline: The Next Portfolio Vaccine?
Article By: The Dividend Guy
Thursday, February 14, 2019 3:01 PM EDT
The current stock price is considered overpriced for the value an investor would get in return. Dividends are satisfying, but there are no growth promises in the foreseeable future.
In this article: GSK
Read
Pfizer, GSK To Merge Consumer Healthcare Units Into Joint Venture
Article By: The Fly
Wednesday, December 19, 2018 11:27 AM EDT
Pfizer and GlaxoSmithKline announced they have entered into an agreement to create a consumer healthcare company.
In this article: GSK, PFE
Read
Tesaro To Be Acquired By GSK For Aggregate Consideration Of Approx. $5.1B
Article By: The Fly
Monday, December 3, 2018 10:20 AM EDT
GlaxoSmithKline and Tesaro Inc. announced that the companies have entered into a definitive agreement pursuant to which GSK will acquire Tesaro Inc.
In this article: GSK, TSRO
Read
Glaxo (GSK) Beats On Q3 Earnings & Sales, Raises '18 View
Article By: Zacks Investment Research
Friday, November 2, 2018 3:00 PM EDT
GlaxoSmithKline plc GSK​ reported core earnings of 93 cents per American depositary share in the third quarter of 2018, which beat the Zacks Consensus Estimate of 86 cents. Earnings were up 14% at constant exchange rate from the year-ago figure.
In this article: GSK Also: LLY, NVS, MYL
Read

PARTNER HEADLINES

Latest Tweets for $GSK

No tweets yet!